Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial
CHRU Nancy - Centre Hospitalier Régional Universitaire de Nancy (Siège social : 29 avenue du Maréchal de Lattre de Tassigny, CO 60034, 54035 NANCY CEDEX
Hôpital Central : 29 Avenue du Maréchal de Lattre de Tassigny, 54035 Nancy
Hôpitaux de Brabois / Enfants : Rue du Morvan, 54500 Vandœuvre-lès-Nancy
Maternité régionale :10 Avenue Dr Heydenreich, 54000 Nancy - France)
https://hal.univ-lorraine.fr/hal-02865493
Contributor : Philippe de Carvalho <>
Submitted on : Thursday, June 11, 2020 - 6:08:33 PM Last modification on : Thursday, January 7, 2021 - 4:00:03 PM
Johannes Petutschnigg, Joao Pedro Ferreira, Volker Holzendorf, Tobias Trippel, Djawid Hashemi, et al.. Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial. European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (3), pp.559-561. ⟨10.1002/ejhf.1723⟩. ⟨hal-02865493⟩